Top Markets
#1 Akedo Akedo +48.15%
#2 TENDIES TENDIES +44.80%
#3 Threshold Network Threshold Network +41.90%
#4 Mubarak Mubarak +24.91%
#5 Cash Cat Cash Cat +20.67%
#6 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
#7 MultiversX MultiversX +17.21%
#8 Magma Finance Magma Finance +16.65%
#9 OSK OSK +16.18%
#10 Kite Kite +15.76%
Coin of the day
Akedo Akedo
設定
言語
日本
通貨
USD
テーマ
TWi Biotechnology, Inc. TWi Biotechnology, Inc.

TWi Biotechnology, Inc.

6610
株式のランク #17311
TWi Biotechnology, Inc. operates as a clinical-stage biopharmaceutical firm,... TWi Biotechnology, Inc. operates as a clinical-stage biopharmaceutical firm, concentrating on the development and sale of medications designed to address innate immunity disorders, primarily within Taiwan. The company's drug pipeline notably includes AC-203, which is currently undergoing Phase 2 clinical trials for various conditions such as epidermolysis bullosa simplex, epidermolysis bullosa, arthritis, gout, and diabetes mellitus. Additionally, AC-1101 is in Phase 1 trials for vitiligo treatment and is advancing through preclinical stages for atopic dermatitis, granuloma annulare, and other uncommon autoimmune skin diseases. TWi Biotechnology has also established a drug development collaboration with Hong Kong Winhealth Pharma Group Co., Limited, targeting the markets of Mainland China, Hong Kong, and Macao. Founded in 2010, the company is headquartered in Taipei, Taiwan.
株価
$1.21
時価総額
$248.41M
変化（1日）
4.11%
変化（1年）
79.12%
国
TW
取引 TWi Biotechnology, Inc. (6610)

カテゴリー

Healthcare
TWi Biotechnology, Inc.（6610）の収益
Sep 2026 時点の収益 TTM: 0
TWi Biotechnology, Inc. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
TWi Biotechnology, Inc. の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH